Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection.

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Biology

Immunology

Physics

Acoustics

Virology

Show all topics

DOI

10.1101/2022.11.08.515436

License

CC-BY

Other Formats

PDF